In this episode of The Further, Faster podcast, Jeff Becker sits down with Caspar Barnes, the founder of AminoChain. Caspar's journey began at age 12 when a diagnosis of malignant melanoma sparked a lifelong fascination with biology. After discovering that patients lose all "agency" over their bio-samples once they leave the operating room, Caspar set out to build a decentralized research ecosystem. Now, after raising $7.8 million from Andreessen Horowitz (a16z), AminoChain is building a platform that lets patients track how their donated samples are used in preclinical and clinical research—and even earn money back when those samples are commercialized. This episode is a must-watch for aspiring founders, biotech enthusiasts, and patient advocates who want to see how a personal experience with cancer transformed into a mission to give patients true agency and financial stakes in the multi-billion dollar medical research industry.

Follow the Further, Faster Podcast 🎧

https://open.spotify.com/show/4apXHaroSIyxAPK6sdJp4R?si=ce0fcd7bedc74ef2

Find out more👇

https://linktr.ee/antler.global

About Antler 🚀

Antler is where exceptional founders come to go further, faster. Join our community of world-class talent and dedicate yourself to the most meaningful work of your life — building the next category-defining company.

This content is provided for informational purposes only and does not constitute legal, business, tax, or investment advice. It does not constitute an invitation or recommendation to purchase or subscribe for, and should not be relied upon when making any investment decision in; any Antler fund, or any other investment or instrument.

#startupjourney #venturecapital #buildwithantler